Peripheral nerve injury (PNI), one of the most common concerns following trauma, can result in a significant loss of sensory or motor function. Restoration of the injured nerves requires a complex ...cellular and molecular response to rebuild the functional axons so that they can accurately connect with their original targets. However, there is no optimized therapy for complete recovery after PNI. Supplementation with exogenous growth factors (GFs) is an emerging and versatile therapeutic strategy for promoting nerve regeneration and functional recovery. GFs activate the downstream targets of various signaling cascades through binding with their corresponding receptors to exert their multiple effects on neurorestoration and tissue regeneration. However, the simple administration of GFs is insufficient for reconstructing PNI due to their short half‑life and rapid deactivation in body fluids. To overcome these shortcomings, several nerve conduits derived from biological tissue or synthetic materials have been developed. Their good biocompatibility and biofunctionality made them a suitable vehicle for the delivery of multiple GFs to support peripheral nerve regeneration. After repairing nerve defects, the controlled release of GFs from the conduit structures is able to continuously improve axonal regeneration and functional outcome. Thus, therapies with growth factor (GF) delivery systems have received increasing attention in recent years. Here, we mainly review the therapeutic capacity of GFs and their incorporation into nerve guides for repairing PNI. In addition, the possible receptors and signaling mechanisms of the GF family exerting their biological effects are also emphasized.
The photocatalytic reduction of CO2 to energy carriers has emerged as one of the most promising strategies to alleviate the energy crisis and CO2 pollution, for which the development of catalyst was ...considered as the determining factor for the accomplishment of this conversion process. In this study, three stable and isostructural metal–organic frameworks (denoted as MOF-Ni, MOF-Co, and MOF-Cu) have been synthesized and used as heterogeneous catalysts in photocatalytic CO2 reduction reaction (CO2RR). It is worth noting that the MOF-Ni exhibited very high selectivity of 97.7% for photoreducing CO2 to CO, which has exceeded most of the reported MOF-based catalysts in the field. Significantly, the MOFs associated with a monometallic catalytic center offer a simple and precise structural model which allows us to understand more definitively the specific effects of different metal-ion species on photoreduction of CO2 as well as the reactive mechanism.
Chitosan modification is an important method for the development of adsorbents that has attracted considerable interest in recent years. In this regard, a new type of efficient Pb(II) adsorbent was ...prepared in a simple and cost-effective way. In this study, carboxylated chitosan (CYCS) and carboxylated nanocellulose (CNC) were used to chelate and synthesize hydrogel spheres with effective adsorption sites, in calcium chloride solution. The prepared carboxylated chitosan/carboxylated nanocellulose (CYCS/CNC) hydrogel beads were used as Pb(II) adsorbents, and using scanning electron microscopy, Fourier transform infrared spectroscopy, and X-ray photoelectron spectroscopy, the structure and adsorption properties of the prepared beads were investigated. The CYCS/CNC adsorbents exhibited an excellent aqueous Pb(II) adsorption capacity (qm = 334.92 mg g−1), and the experimental results further revealed that the adsorption data fitted well with the Langmuir model, and the adsorption kinetics accorded with the pseudo-second-order model. Additionally, the adsorption mechanism was identified as monolayer chemisorption.
Display omitted
•Efficient and economic CYCS/CNC composite is prepared for Pb(II) adsorption.•CYCS/CNC exhibits excellent aqueous Pb(II) adsorption capacity (Qm = 334.92 mg g−1).•Adsorption mechanism of CYCS/CNC includes chemical and electrostatic adsorption.•The adsorption performance is good even after four regeneration cycles.
Herein we report a new type of adsorbent for the efficient removal of Pb(II), which is prepared from cellulose nanofiber (CNF) and sodium alginate (SA) via a simple cross-linking method. During this ...process, the porous structure of the hydrogel beads was formed by the disintegration of calcium phosphate. The performance and structure of the prepared beads were systematically examined by X-ray photoelectron spectroscopy, Fourier-transform infrared spectroscopy, zeta potential measurements, and scanning electron microscopy. Investigations revealed that the adsorption equilibrium was attained after approximately 120 min. In addition, 82% of Pb(II) ions were absorbed in the initial 40 min at 297 K. The adsorption process was consistent with a pseudo-second order kinetic model and the Langmuir adsorption isotherm model, and the limit adsorption capacity reached 318.47 mg g−1. Acid treatment and regeneration experiments verified that the adsorption capacity of Pb(II) on the beads was satisfactory, and the adsorption rate remained at >80% after 5 cycles. These results indicate that the prepared beads are potential adsorbents for water treatment.
Display omitted
•Beads cellulose nanofiber alginate hydrogel beads were prepared by cross-linking.•In Pb(II) ion removal from aqueous solution, 82% of ions were adsorbed in 40 min.•A chemical adsorption mechanism via a single-layer process dominated.•The adsorption rate remained >80% (100% = 318.47 mg g−1) after 5 cycles.
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with an increasing case number and extensive geographical expansion, raising concerns locally and globally; ...however, the description of its clinical features needs to be addressed by large studies. We aimed to determine all the clinical features of SFTS in a large population of patients in an endemic area.
In this prospective observational study, data were collected on patients admitted to the People's Liberation Army Hospital in Xinyang, Henan Province, China, with laboratory-diagnosed SFTS. Demographic, clinical, laboratory, and treatment data were collected for each patient, and patients were followed up within 2 weeks after discharge or discontinuation of treatment. The association between each demographic, clinical, and laboratory variable with a fatal outcome was assessed. A clinical scoring model was designed for the early prediction of a fatal outcome, and the effect of treatment on outcome was analysed.
Between April 1, 2011, and Oct 31, 2017, 2096 patients with laboratory-confirmed SFTS were admitted. Mean age at admission was 61·4 years (SD 12·2) and 1239 (59%) patients were female. The case fatality rate (CFR) was 16·2% (95% CI 14·6–17·8). A higher risk was associated with being male (unadjusted odds ratio OR 1·45, 95% CI 1·15–1·83; p=0·002), older age (for a 10-year increase, unadjusted OR 1·82, 95% CI 1·62–2·04; p<0·0001), longer delay in admission (for every extra day taken before admission to hospital, unadjusted OR 1·18, 1·12–1·24; p<0·0001), presence of diarrhoea (adjusted OR 1·44, 1·12–1·87; p=0·005) or dyspnoea (adjusted OR 8·35, 5·97–11·69; p<0·0001), and development of haemorrhagic signs (adjusted OR 2·79, 95% CI 2·18–3·57; p<0·0001) or neurological symptoms (adjusted OR 30·26, 21·39–42·81; p<0·0001). Laboratory variables that were associated with death included abnormal concentrations of lactate dehydrogenase, aspartate aminotransferase, and blood urea nitrogen, and abnormal neutrophil percentage, which together with age and neurological symptoms were combined in the clinical scoring system. A total score of more than 8 was the optimal threshold to predict risk of death for patients who were evaluated within 6 days after symptom onset (area under the curve 0·879, 95% CI 0·855–0·902). For all participants, viraemia was a strong predictor of fatal outcome (all p<0·0001). Ribavirin therapy was effective in reducing CFR from 6·25% (15 of 240 participants) to 1·16% (two of 173 participants), but only in patients with a viral load below 1×106 copies per mL (hazard ratio 9·72, 95% CI 1·30–72·87; p=0·027).
The changing epidemiological features and high CFR of SFTS underscore the necessity of continued surveillance. Early prediction of fatal outcome can be attained by monitoring of clinical and laboratory data. Ribavirin should be applied early, with best results achieved before the viral load reaches 1 × 106 copies per mL.
National Natural Science Foundation of China.
As a typical metal–organic framework material, UiO-66 has good potential for removing pharmaceuticals and personal care products from water. However, the application of this powdery adsorbent has ...been limited by the difficult recovery from the liquid. To overcome this weakness, we prepared composite beads constituted by sodium alginate and UiO-66 by solidification in CaCl
2
solution. The material was characterized by SEM, FTIR, XRD, BET, and TGA methods. These composite beads were applied to remove a common antibiotic Levofloxacin (LOFX) from water, and the experimental parameters (i.e., initial LOFX concentration, adsorption time, pH, and adsorbent dose) were optimized. The adsorption data could be satisfactorily fitted to the Langmuir isotherm model (
R
2
= 0.9871) and the pseudo-second-order kinetic model (
R
2
= 0.9990). The regeneration experiment of the composite beads revealed that the adsorption efficiency of levofloxacin was higher than 70% even after 5 cycles.
Scheme 1 Synthesis route of UiO-66/CA
Lung macrophages play important roles in the maintenance of homeostasis, pathogen clearance and immune regulation. The different types of pulmonary macrophages and their roles in lung diseases have ...attracted attention in recent years. Alveolar macrophages (AMs), including tissue-resident alveolar macrophages (TR-AMs) and monocyte-derived alveolar macrophages (Mo-AMs), as well as interstitial macrophages (IMs) are the major macrophage populations in the lung and have unique characteristics in both steady-state conditions and disease states. The different characteristics of these three types of macrophages determine the different roles they play in the development of disease. Therefore, it is important to fully understand the similarities and differences among these three types of macrophages for the study of lung diseases. In this review, we will discuss the physiological characteristics and unique functions of these three types of macrophages in acute and chronic lung diseases. We will also discuss possible methods to target macrophages in lung diseases.
Total knee arthroplasty (TKA) is one of the most common surgeries performed to relieve joint pain in patients with end‐stage osteoarthritis or rheumatic arthritis of the knee. However, TKA is ...followed by moderate to severe postoperative pain that affects postoperative rehabilitation, patient satisfaction, and overall outcomes. Historically, opioids have been widely used for perioperative pain management of TKA. However, opioids are associated with undesirable adverse effects, such as nausea, respiratory depression, and retention of urine, which limit their application in daily clinical practice. The aim of this review was to discuss the current postoperative pain management regimens for TKA. Our review of the literature demonstrated that multimodal analgesia is considered the optimal regimen for perioperative pain management of TKA and improves clinical outcomes and patient satisfaction, through a combination of several types of medications and delivery routes, including preemptive analgesia, neuraxial anesthesia, peripheral nerve blockade, patient‐controlled analgesia and local infiltration analgesia, and oral opioid/nonopioid medications. Multimodal analgesia provides superior pain relief, promotes recovery of the knee, and reduces opioid consumption and related adverse effects in patients undergoing TKA.
Display omitted
We synthesized composite microspheres from cellulose nanocrystal (CNC), polyvinyl alcohol (PVA), and sodium alginate (SA), which were modified with polyethyleneimine (PEI) to ...introduce a high density of active amino sites onto the surface via the Schiff base reaction. We hypothesized that these (SA/CNC/PVA)@PEI microspheres would have a high adsorption capacity for aqueous diclofenac sodium (DS).
The PEI-modified composite microspheres were characterized and assessed and optimized for aqueous DS adsorption. In addition, the morphology and synthesis mechanism of the adsorbent were studied.
The adsorption process showed a good fit with the pseudo-second-order kinetic model (i.e., the process is driven by a chemical adsorption mechanism) and Langmuir adsorption isotherm model (i.e., adsorption follows a single-layer process). Under the optimum experimental conditions (pH: 4.5, adsorption time: 50 min, temperature: 303 K), the maximum adsorption capacity was 418.4104 mg/g, which was relatively high compared to other reported adsorbents. Importantly, after five adsorption–desorption cycles, (SA/CNC/PVA)@PEI showed only a slight loss in adsorption capacity. Compared with other reported adsorbents, the core–shell composite has a good DS adsorptive capacity and high recyclability.
Ischaemia‐reperfusion injury (I/RI) is a common cause of acute kidney injury (AKI). The molecular basis underlying I/RI‐induced renal pathogenesis and measures to prevent or reverse this pathologic ...process remains to be resolved. Basic fibroblast growth factor (FGF2) is reported to have protective roles of myocardial infarction as well as in several other I/R related disorders. Herein we present evidence that FGF2 exhibits robust protective effect against renal histological and functional damages in a rat I/RI model. FGF2 treatment greatly alleviated I/R‐induced acute renal dysfunction and largely blunted I/R‐induced elevation in serum creatinine and blood urea nitrogen, and also the number of TUNEL‐positive tubular cells in the kidney. Mechanistically, FGF2 substantially ameliorated renal I/RI by mitigating several mitochondria damaging parameters including pro‐apoptotic alteration of Bcl2/Bax expression, caspase‐3 activation, loss of mitochondrial membrane potential and KATP channel integrity. Of note, the protective effect of FGF2 was significantly compromised by the KATP channel blocker 5‐HD. Interestingly, I/RI alone resulted in mild activation of FGFR, whereas FGF2 treatment led to more robust receptor activation. More significantly, post‐I/RI administration of FGF2 also exhibited robust protection against I/RI by reducing cell apoptosis, inhibiting the release of damage‐associated molecular pattern molecule HMBG1 and activation of its downstream inflammatory cytokines such as IL‐1α, IL‐6 and TNF α. Taken together, our data suggest that FGF2 offers effective protection against I/RI and improves animal survival by attenuating mitochondrial damage and HMGB1‐mediated inflammatory response. Therefore, FGF2 has the potential to be used for the prevention and treatment of I/RI‐induced AKI.
PDF
